About Jeffrey Kindler
Form D filings for Centrexion Therapeutics from 2013 to 2024 list Jeffrey Kindler as executive officer and director.
Jeffrey Kindler first appears on SEC filings in 2013.
Experience
This experience comes from SEC filings. The years are when the filings name Jeffrey Kindler in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jeffrey Kindler works with at each company, as listed on that company's latest Form D.
Centrexion Therapeutics Corp · Form D, Jan 8, 2024
ST
Shawn Tomasello
Director
MW
Michael Ward
Chief Financial Officer, Treasurer, and Secretary
JD
James Campbell, M.D.
Executive officer and director
SD
Sol Barer, Ph.D.
Director
CH
Colin Hill
Director
RS
Randall Stevens
Executive officer
JS
Joseph Swedish
Director
JD
J.c. Lopez, M.D.
Director